ROCKWELL MEDICAL, INC. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
ROCKWELL MEDICAL, INC. (RMTI) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $491.08 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-10.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2018-05-10
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2018-03-31 was $491.08K, a 56.41% decline year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2017-12-31 was $494.68K, a 54.64% decline year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2017-09-30 was $494.67K, a 54.64% decline year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2017-06-30 was $971.37K, a 10.92% decline year-over-year.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2017 was $3.09M, a 29.22% decline from fiscal 2016.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2016 was $4.36M, a 18.06% increase from fiscal 2015.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2015 was $3.69M, a 32.79% decline from fiscal 2014.
- ROCKWELL MEDICAL, INC. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2014 was $5.50M, a 180.26% increase from fiscal 2013.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2018-03-31 | $491.08K 10-Q · filed 2018-05-10 | $985.75K derived: sum of 2 quarters · filed 2018-05-10 | $1.48M derived: sum of 3 quarters · filed 2018-05-10 | $2.45M derived: sum of 4 quarters · filed 2018-05-10 |
| 2017-12-31 | $494.68K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $989.35K derived: sum of 2 quarters · filed 2018-03-15 | $1.96M derived: sum of 3 quarters · filed 2018-03-15 | $3.09M 10-K · filed 2018-03-15 |
| 2017-09-30 | $494.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $1.47M derived: sum of 2 quarters · filed 2017-11-08 | $2.59M 10-Q · filed 2017-11-08 | $3.68M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-06-30 | $971.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $2.10M 10-Q · filed 2017-08-09 | $3.19M derived: sum of 3 quarters · filed 2018-03-15 | $4.28M derived: sum of 4 quarters · filed 2018-03-15 |
| 2017-03-31 | $1.13M 10-Q · filed 2017-05-09 | $2.22M derived: sum of 2 quarters · filed 2018-03-15 | $3.31M derived: sum of 3 quarters · filed 2018-03-15 | $4.40M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-12-31 | $1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $2.18M derived: sum of 2 quarters · filed 2018-03-15 | $3.27M derived: sum of 3 quarters · filed 2018-03-15 | $4.36M 10-K · filed 2018-03-15 |
| 2016-09-30 | $1.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $2.18M derived: sum of 2 quarters · filed 2016-11-07 | $3.27M 10-Q · filed 2016-11-07 | $4.36M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-06-30 | $1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $2.18M 10-Q · filed 2016-08-09 | $3.27M derived: sum of 3 quarters · filed 2018-03-15 | $3.27M derived: sum of 4 quarters · filed 2018-03-15 |
| 2016-03-31 | $1.09M 10-Q · filed 2016-05-10 | $2.17M derived: sum of 2 quarters · filed 2018-03-15 | $2.17M derived: sum of 3 quarters · filed 2018-03-15 | $2.71M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $1.08M derived: sum of 2 quarters · filed 2018-03-15 | $1.62M derived: sum of 3 quarters · filed 2018-03-15 | $3.69M 10-K · filed 2018-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $532.80K derived: sum of 2 quarters · filed 2015-11-09 | $2.61M 10-Q · filed 2015-11-09 | $4.93M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-06-30 | $532.80K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $2.61M 10-Q · filed 2015-08-04 | $4.93M derived: sum of 3 quarters · filed 2017-03-15 | $5.77M derived: sum of 4 quarters · filed 2017-03-15 |
| 2015-03-31 | $2.08M 10-Q · filed 2015-05-07 | $4.39M derived: sum of 2 quarters · filed 2017-03-15 | $5.24M derived: sum of 3 quarters · filed 2017-03-15 | $6.44M derived: sum of 4 quarters · filed 2017-03-15 |
| 2014-12-31 | $2.32M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $3.16M derived: sum of 2 quarters · filed 2017-03-15 | $4.36M derived: sum of 3 quarters · filed 2017-03-15 | $5.50M 10-K · filed 2017-03-15 |
| 2014-09-30 | $846.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $2.04M derived: sum of 2 quarters · filed 2014-11-10 | $3.18M 10-Q · filed 2014-11-10 | $3.72M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | $2.33M 10-Q · filed 2014-07-31 | $2.87M derived: sum of 3 quarters · filed 2016-02-29 | $3.47M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $1.14M 10-Q · filed 2014-05-12 | $1.68M derived: sum of 2 quarters · filed 2016-02-29 | $2.27M derived: sum of 3 quarters · filed 2016-02-29 | $2.71M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $539.32K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.13M derived: sum of 2 quarters · filed 2016-02-29 | $1.57M derived: sum of 3 quarters · filed 2016-02-29 | $1.96M 10-K · filed 2016-02-29 |
| 2013-09-30 | $593.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | $1.03M derived: sum of 2 quarters · filed 2013-11-05 | $1.42M 10-Q · filed 2013-11-05 | $1.81M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-06-30 | $437.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $828.76K 10-Q · filed 2013-08-01 | $1.22M derived: sum of 3 quarters · filed 2015-03-03 | $1.61M derived: sum of 4 quarters · filed 2015-03-03 |
| 2013-03-31 | $390.81K 10-Q · filed 2013-05-08 | $783.20K derived: sum of 2 quarters · filed 2015-03-03 | $1.18M derived: sum of 3 quarters · filed 2015-03-03 | $1.35M derived: sum of 4 quarters · filed 2015-03-03 |
| 2012-12-31 | $392.39K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | $784.77K derived: sum of 2 quarters · filed 2015-03-03 | $961.13K derived: sum of 3 quarters · filed 2015-03-03 | $1.08M 10-K · filed 2015-03-03 |
| 2012-09-30 | $392.39K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $568.75K derived: sum of 2 quarters · filed 2012-11-09 | $683.54K 10-Q · filed 2012-11-09 | $819.33K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | $176.36K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $291.15K 10-Q · filed 2012-08-07 | $426.94K derived: sum of 3 quarters · filed 2014-03-07 | $580.35K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-03-31 | $114.79K 10-Q · filed 2012-05-07 | $250.58K derived: sum of 2 quarters · filed 2014-03-07 | $403.99K derived: sum of 3 quarters · filed 2014-03-07 | |
| 2011-12-31 | $135.79K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | $289.19K derived: sum of 2 quarters · filed 2014-03-07 | $596.00K 10-K · filed 2014-03-07 | |
| 2011-09-30 | $153.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $460.21K 10-Q · filed 2011-11-04 | ||
| 2011-06-30 | $306.81K 10-Q · filed 2011-08-05 | |||
| 2010-12-31 | $332.64K 10-K · filed 2013-03-18 | |||
| 2009-12-31 | $154.44K 10-K · filed 2012-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B |